| Product Code: ETC13167612 | Publication Date: Apr 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 150 | No. of Figures: 55 | No. of Tables: 32 |
Europe Pharmacovigilance Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Europe Pharmacovigilance Market Overview |
3.1 Europe Regional Macro Economic Indicators |
3.2 Europe Pharmacovigilance Market Revenues & Volume, 2021 & 2031F |
3.3 Europe Pharmacovigilance Market - Industry Life Cycle |
3.4 Europe Pharmacovigilance Market - Porter's Five Forces |
3.5 Europe Pharmacovigilance Market Revenues & Volume Share, By Countries, 2021 & 2031F |
3.6 Europe Pharmacovigilance Market Revenues & Volume Share, By Clinical Trial Phase, 2021 & 2031F |
3.7 Europe Pharmacovigilance Market Revenues & Volume Share, By Service Provider, 2021 & 2031F |
3.8 Europe Pharmacovigilance Market Revenues & Volume Share, By Type of Reporting, 2021 & 2031F |
3.9 Europe Pharmacovigilance Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Europe Pharmacovigilance Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Europe Pharmacovigilance Market Trends |
6 Europe Pharmacovigilance Market, 2021 - 2031 |
6.1 Europe Pharmacovigilance Market, Revenues & Volume, By Clinical Trial Phase, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Europe Pharmacovigilance Market, Revenues & Volume, By Preclinical, 2021 - 2031 |
6.1.3 Europe Pharmacovigilance Market, Revenues & Volume, By Phase I, 2021 - 2031 |
6.1.4 Europe Pharmacovigilance Market, Revenues & Volume, By Phase II, 2021 - 2031 |
6.1.5 Europe Pharmacovigilance Market, Revenues & Volume, By Phase III, 2021 - 2031 |
6.1.6 Europe Pharmacovigilance Market, Revenues & Volume, By Phase IV, 2021 - 2031 |
6.2 Europe Pharmacovigilance Market, Revenues & Volume, By Service Provider, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Europe Pharmacovigilance Market, Revenues & Volume, By In-house, 2021 - 2031 |
6.2.3 Europe Pharmacovigilance Market, Revenues & Volume, By Contract Outsourcing, 2021 - 2031 |
6.3 Europe Pharmacovigilance Market, Revenues & Volume, By Type of Reporting, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Europe Pharmacovigilance Market, Revenues & Volume, By Spontaneous Reporting, 2021 - 2031 |
6.3.3 Europe Pharmacovigilance Market, Revenues & Volume, By Intensified ADR Reporting, 2021 - 2031 |
6.3.4 Europe Pharmacovigilance Market, Revenues & Volume, By Targeted Spontaneous Reporting, 2021 - 2031 |
6.3.5 Europe Pharmacovigilance Market, Revenues & Volume, By Cohort Event Monitoring, 2021 - 2031 |
6.3.6 Europe Pharmacovigilance Market, Revenues & Volume, By EHR Mining, 2021 - 2031 |
6.4 Europe Pharmacovigilance Market, Revenues & Volume, By End User, 2021 - 2031 |
6.4.1 Overview & Analysis |
6.4.2 Europe Pharmacovigilance Market, Revenues & Volume, By Hospitals, 2021 - 2031 |
6.4.3 Europe Pharmacovigilance Market, Revenues & Volume, By Pharmaceutical Companies, 2021 - 2031 |
6.4.4 Europe Pharmacovigilance Market, Revenues & Volume, By Other End Users, 2021 - 2031 |
7 Europe Pharmacovigilance Market, By Countries, 2021 - 2031 |
7.1 Overview & Analysis |
7.2 Europe Pharmacovigilance Market, Revenues & Volume, By Clinical Trial Phase, 2021 - 2031 |
7.2.1 United Kingdom (UK) Pharmacovigilance Market, Revenues & Volume, By Clinical Trial Phase, 2021 - 2031 |
7.2.2 Germany Pharmacovigilance Market, Revenues & Volume, By Clinical Trial Phase, 2021 - 2031 |
7.2.3 France Pharmacovigilance Market, Revenues & Volume, By Clinical Trial Phase, 2021 - 2031 |
7.2.4 Poland Pharmacovigilance Market, Revenues & Volume, By Clinical Trial Phase, 2021 - 2031 |
7.2.5 Spain Pharmacovigilance Market, Revenues & Volume, By Clinical Trial Phase, 2021 - 2031 |
7.2.6 Rest of Europe Pharmacovigilance Market, Revenues & Volume, By Clinical Trial Phase, 2021 - 2031 |
7.3 Europe Pharmacovigilance Market Revenues & Volume Share, By Service Provider, 2021 & 2031F |
7.3.1 United Kingdom (UK) Pharmacovigilance Market, Revenues & Volume, By Service Provider, 2021 - 2031 |
7.3.2 Germany Pharmacovigilance Market, Revenues & Volume, By Service Provider, 2021 - 2031 |
7.3.3 France Pharmacovigilance Market, Revenues & Volume, By Service Provider, 2021 - 2031 |
7.3.4 Poland Pharmacovigilance Market, Revenues & Volume, By Service Provider, 2021 - 2031 |
7.3.5 Spain Pharmacovigilance Market, Revenues & Volume, By Service Provider, 2021 - 2031 |
7.3.6 Rest of Europe Pharmacovigilance Market, Revenues & Volume, By Service Provider, 2021 - 2031 |
7.4 Europe Pharmacovigilance Market, Revenues & Volume, By Type of Reporting, 2021 - 2031 |
7.4.1 United Kingdom (UK) Pharmacovigilance Market, Revenues & Volume, By Type of Reporting, 2021 - 2031 |
7.4.2 Germany Pharmacovigilance Market, Revenues & Volume, By Type of Reporting, 2021 - 2031 |
7.4.3 France Pharmacovigilance Market, Revenues & Volume, By Type of Reporting, 2021 - 2031 |
7.4.4 Poland Pharmacovigilance Market, Revenues & Volume, By Type of Reporting, 2021 - 2031 |
7.4.5 Spain Pharmacovigilance Market, Revenues & Volume, By Type of Reporting, 2021 - 2031 |
7.4.6 Rest of Europe Pharmacovigilance Market, Revenues & Volume, By Type of Reporting, 2021 - 2031 |
7.5 Europe Pharmacovigilance Market, Revenues & Volume, By End User, 2021 - 2031 |
7.5.1 United Kingdom (UK) Pharmacovigilance Market, Revenues & Volume, By End User, 2021 - 2031 |
7.5.2 Germany Pharmacovigilance Market, Revenues & Volume, By End User, 2021 - 2031 |
7.5.3 France Pharmacovigilance Market, Revenues & Volume, By End User, 2021 - 2031 |
7.5.4 Poland Pharmacovigilance Market, Revenues & Volume, By End User, 2021 - 2031 |
7.5.5 Spain Pharmacovigilance Market, Revenues & Volume, By End User, 2021 - 2031 |
7.5.6 Rest of Europe Pharmacovigilance Market, Revenues & Volume, By End User, 2021 - 2031 |
8 Europe Pharmacovigilance Market Key Performance Indicators |
9 Europe Pharmacovigilance Market - Export/Import By Countries Assessment |
10 Europe Pharmacovigilance Market - Opportunity Assessment |
10.1 Europe Pharmacovigilance Market Opportunity Assessment, By Countries, 2021 & 2031F |
10.2 Europe Pharmacovigilance Market Opportunity Assessment, By Clinical Trial Phase, 2021 & 2031F |
10.3 Europe Pharmacovigilance Market Opportunity Assessment, By Service Provider, 2021 & 2031F |
10.4 Europe Pharmacovigilance Market Opportunity Assessment, By Type of Reporting, 2021 & 2031F |
10.5 Europe Pharmacovigilance Market Opportunity Assessment, By End User, 2021 & 2031F |
11 Europe Pharmacovigilance Market - Competitive Landscape |
11.1 Europe Pharmacovigilance Market Revenue Share, By Companies, 2022 |
11.2 Europe Pharmacovigilance Market Competitive Benchmarking, By Operating and Technical Parameters |
12 Top 10 Company Profiles |
13 Recommendations |
14 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here